These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 21275601)

  • 1. Vitreous web after pars plana vitrectomy and bevacizumab with fluid-air exchange.
    Chiang A; Reddy S; Tsui I; Hubschman JP
    Semin Ophthalmol; 2011 Jan; 26(1):25-7. PubMed ID: 21275601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sterile endophthalmitis after intravitreal injection of bevacizumab obtained from a single batch.
    Yamashiro K; Tsujikawa A; Miyamoto K; Oh H; Otani A; Tamuara H; Ooto S; Sasahara M; Iwama D; Yoshimura N
    Retina; 2010 Mar; 30(3):485-90. PubMed ID: 19952993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ghost cell glaucoma after intravitreal bevacizumab for postoperative vitreous hemorrhage following vitrectomy for proliferative diabetic retinopathy.
    Liu L; Wu WC; Yeung L; Wang NK; Kuo YH; Chao AN; Chen KJ; Chen TL; Lai CC; Hwang YS; Chen YP
    Ophthalmic Surg Lasers Imaging; 2010; 41(1):72-7. PubMed ID: 20128573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Combined pharmacosurgery as treatment for diabetic macular edema: core pars plana vitrectomy and intravitreal injection of bevacizumab and triamcinolone].
    Naser H; Koss MJ; Singh P; Koch F
    Klin Monbl Augenheilkd; 2011 Oct; 228(10):910-4. PubMed ID: 21997827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitreous and plasma concentrations of apelin and vascular endothelial growth factor after intravitreal bevacizumab in eyes with proliferative diabetic retinopathy.
    Qian J; Lu Q; Tao Y; Jiang YR
    Retina; 2011 Jan; 31(1):161-8. PubMed ID: 20890241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microincision vitrectomy surgery and intravitreal bevacizumab as a surgical adjunct to treat diabetic traction retinal detachment.
    Oshima Y; Shima C; Wakabayashi T; Kusaka S; Shiraga F; Ohji M; Tano Y
    Ophthalmology; 2009 May; 116(5):927-38. PubMed ID: 19269033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of severe intraocular inflammation following intravitreal injection of bevacizumab (Avastin).
    Georgopoulos M; Polak K; Prager F; Prünte C; Schmidt-Erfurth U
    Br J Ophthalmol; 2009 Apr; 93(4):457-62. PubMed ID: 19033289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravitreal anti-vascular endothelial growth factor therapy with bevacizumab for tuberous sclerosis with macular oedema.
    Saito W; Kase S; Ohgami K; Mori S; Ohno S
    Acta Ophthalmol; 2010 May; 88(3):377-80. PubMed ID: 18778334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term effect of intravitreal bevacizumab (avastin) in patients with chronic diffuse diabetic macular edema.
    Kook D; Wolf A; Kreutzer T; Neubauer A; Strauss R; Ulbig M; Kampik A; Haritoglou C
    Retina; 2008 Oct; 28(8):1053-60. PubMed ID: 18779710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe intraocular inflammation after intravitreal injection of bevacizumab.
    Sato T; Emi K; Ikeda T; Bando H; Sato S; Morita S; Oyagi T; Sawada K
    Ophthalmology; 2010 Mar; 117(3):512-6, 516.e1-2. PubMed ID: 20031229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bevacizumab (Avastin) for diabetic macular edema in previously vitrectomized eyes.
    Yanyali A; Aytug B; Horozoglu F; Nohutcu AF
    Am J Ophthalmol; 2007 Jul; 144(1):124-6. PubMed ID: 17601433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravitreal bevacizumab (avastin) injection alone or combined with triamcinolone versus macular photocoagulation as primary treatment of diabetic macular edema.
    Soheilian M; Ramezani A; Bijanzadeh B; Yaseri M; Ahmadieh H; Dehghan MH; Azarmina M; Moradian S; Tabatabaei H; Peyman GA
    Retina; 2007; 27(9):1187-95. PubMed ID: 18046223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema.
    Haritoglou C; Kook D; Neubauer A; Wolf A; Priglinger S; Strauss R; Gandorfer A; Ulbig M; Kampik A
    Retina; 2006; 26(9):999-1005. PubMed ID: 17151486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of intravitreal bevacizumab (Avastin) injected at the end of diabetic vitrectomy in preventing postoperative recurrent vitreous hemorrhage.
    Cheema RA; Mushtaq J; Al-Khars W; Al-Askar E; Cheema MA
    Retina; 2010; 30(10):1646-50. PubMed ID: 20634777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pars plana vitrectomy in the management of patients diagnosed with endophthalmitis following intravitreal anti-vascular endothelial growth factor injection.
    Chaudhary KM; Romero JM; Ezon I; Fastenberg DM; Deramo VA
    Retina; 2013; 33(7):1407-16. PubMed ID: 23492945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enlargement of the foveal avascular zone in diabetic retinopathy after adjunctive intravitreal bevacizumab (avastin) with pars plana vitrectomy.
    Lee SJ; Koh HJ
    J Ocul Pharmacol Ther; 2009 Apr; 25(2):173-4. PubMed ID: 19284326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of one intravitreal injection of bevacizumab in diabetic macular oedema.
    Kumar V; Ghosh B; Raina UK; Goel N
    Acta Ophthalmol; 2010 Mar; 88(2):e3; author reply e4. PubMed ID: 19549100
    [No Abstract]   [Full Text] [Related]  

  • 18. Bilateral simultaneous intravitreal injections in the office setting.
    Bakri SJ; Risco M; Edwards AO; Pulido JS
    Am J Ophthalmol; 2009 Jul; 148(1):66-9.e1. PubMed ID: 19403114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bevacizumab (Avastin) as an adjunct to vitrectomy in the management of severe proliferative diabetic retinopathy: a prospective case series.
    Abdelhakim MA; Macky TA; Mansour KA; Mortada HA
    Ophthalmic Res; 2011; 45(1):23-30. PubMed ID: 20714187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravitreal bevacizumab for prevention of early postvitrectomy hemorrhage in diabetic patients: a randomized clinical trial.
    Ahmadieh H; Shoeibi N; Entezari M; Monshizadeh R
    Ophthalmology; 2009 Oct; 116(10):1943-8. PubMed ID: 19699531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.